New method for evaluating cancer risk of chemicals is quick, precise, inexpensive

(Boston)–Researchers from Boston University Schools of Medicine (BUSM) and Public Health have developed and evaluated a fast, accurate and cost-effective approach to assessing the carcinogenicity of chemicals–that is, whether exposure to a chemical increases a person’s long-term cancer risk. As a result, they have generated one of the largest toxicogenomics datasets to date, and have…

Details

Jewish General Hospital pioneering new clinical trial to study treating breast cancer without surgery

In a radical departure from established treatment protocols, Dr. Mark Basik, a surgical oncologist at Segal Cancer Centre at the Jewish General Hospital (JGH) and senior investigator at the Lady Davis Institute, is leading an international effort that will lead to a clinical trial to forego surgery in breast cancer patients who show no signs…

Details

High-tech tissue study reveals which cells drive a painful food allergy

IMAGE: This heat map shows single-cell RNA sequencing data from eight types of tissue-resident T cells found in tissues collected from people with eosinophilic esophagitis. T8 cells are not found in… view more  Credit: Cincinnati Children’s CINCINNATI–An eight-year hunt for the cells that drive the extreme childhood food allergy eosinophilic esophagitis (EoE) has identified a potential…

Details